BLOCK LISTING SIX MONTHLY RETURN

RNS Number : 2924P
Scancell Holdings Plc
16 February 2021
 

Scancell Holdings Plc

("Scancell" or the "Company")

 

 

BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 16 February 2021

 

 

Name of applicant:

Scancell Holdings plc

Name of scheme:

Convertible Loan Notes Shares

 

Period of return:

From:

12 August 2020

To:

15 February 2021

Number of securities originally admitted at date of admission

96,774,193 ordinary shares of £0.001 each

12 August 2020

 

Balance of unallotted securities under scheme(s) from previous return:

96,774,193 ordinary shares of £0.001 each

 

Plus:   The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

Nil

Less:   Number of securities issued/allotted under scheme(s) during period:

69,719,566 ordinary shares of £0.001 each

Equals:   Balance under scheme(s) not yet issued/allotted at end of period:

27,054,627 ordinary shares of £0.001 each

 

 

 

 

 

 

 

Name of contact:

Dr Cliff Holloway, CEO

Telephone number of contact:

+44 (0) 20 3727 1000

 

For Further Information:

 

Scancell Holdings plc

 

 

Dr John Chiplin, Chairman

 

+44 (0) 20 3727 1000

Dr Cliff Holloway, CEO

 

 

 

 

 

Panmure Gordon (UK) Limited

 

 

Freddy Crossley/Emma Earl (Corporate Finance)

 

+44 (0) 20 7886 2500

Rupert Dearden (Corporate Broking)

 

 

 

 

 

FTI Consulting

 

 

Simon Conway/Natalie Garland-Collins

 

+44 (0) 20 3727 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BLRZQLFFFLLEBBV
UK 100

Latest directors dealings